Bovine and human lactoferricin peptides: chimeras and new cyclic analogs

Lactoferrin (LF) is an important antimicrobial and immune regulatory protein present in neutrophils and most exocrine secretions of mammals. The antimicrobial activity of LF has been related to the presence of an antimicrobial peptide sequence, called lactoferricin (LFcin), located in the N-terminal region of the protein. The antimicrobial activity of bovine LFcin is considerably stronger than the human version. In this work, chimera peptides combining segments of bovine and human LFcin were generated in order to study their antimicrobial activity and mechanism of action. In addition, the relevance of the conserved disulfide bridge and the resulting cyclic structure of both LFcins were analyzed by using “click chemistry” and sortase A-catalyzed cyclization of the peptides. The N-terminal region of bovine LFcin (residues 17–25 of bovine LF) proved to be very important for the antimicrobial activity of the chimera peptides against E. coli, when combined with the C-terminal region of human LFcin. Similarly the cyclic bovine LFcin analogs generated by “click chemistry” and sortase A preserved the antimicrobial activity of the original peptide, showing the significance of these two techniques in the design of cyclic antimicrobial peptides. The mechanism of action of bovine LFcin and its active derived peptides was strongly correlated with membrane leakage in E. coli and up to some extent with the ability to induce vesicle aggregation. This mechanism was also preserved under conditions of high ionic strength (150 mM NaCl) illustrating the importance of these peptides in a more physiologically relevant system.

[1]  Yizhen Wang,et al.  Comparative antimicrobial activity and mechanism of action of bovine lactoferricin-derived synthetic peptides , 2011, BioMetals.

[2]  R. Campos-Rodríguez,et al.  Lactoferrin-lipopolysaccharide (LPS) binding as key to antibacterial and antiendotoxic effects. , 2012, International immunopharmacology.

[3]  M. Tomita,et al.  A review: The active peptide of lactoferrin , 1994, Acta paediatrica Japonica : Overseas edition.

[4]  J. Brock,et al.  Lactoferrin in human milk: its role in iron absorption and protection against enteric infection in the newborn infant. , 1980, Archives of disease in childhood.

[5]  B. Ames.  ASSAY OF INORGANIC PHOSPHATE, TOTAL PHOSPHATE AND PHOSPHATASE , 1966 .

[6]  P. Valenti,et al.  Lactoferrin , 2005, Cellular and Molecular Life Sciences.

[7]  H. Vogel,et al.  Lactoferricin , 2005, Cellular and Molecular Life Sciences.

[8]  C. B. Park,et al.  Structure-activity analysis of buforin II, a histone H2A-derived antimicrobial peptide: the proline hinge is responsible for the cell-penetrating ability of buforin II. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[9]  K. Yamauchi,et al.  Lactoferrin: an alternative view of its role in human biological fluids. , 2012, Biochemistry and cell biology = Biochimie et biologie cellulaire.

[10]  B. AlexanderDavid,et al.  Lactoferrin: an alternative view of its role in human biological fluids11This article is part of a Special Issue entitled Lactoferrin and has undergone the Journal's usual peer review process. , 2012 .

[11]  H. Nikaido.  Molecular Basis of Bacterial Outer Membrane Permeability Revisited , 2003, Microbiology and Molecular Biology Reviews.

[12]  P. Valenti,et al.  LF immunomodulatory strategies: mastering bacterial endotoxin. , 2012, Biochemistry and cell biology = Biochimie et biologie cellulaire.

[13]  M. Tomita,et al.  Antibacterial spectrum of lactoferricin B, a potent bactericidal peptide derived from the N-terminal region of bovine lactoferrin. , 1992, The Journal of applied bacteriology.

[14]  Ø. Olsvik,et al.  Lactoferricin B causes depolarization of the cytoplasmic membrane of Escherichia coli ATCC 25922 and fusion of negatively charged liposomes , 2001, FEBS letters.

[15]  P. Visca,et al.  Interaction of lactoferrin with Escherichia coli cells and correlation with antibacterial activity , 2004, Medical Microbiology and Immunology.

[16]  J. Krijgsveld,et al.  Thrombocidins, Microbicidal Proteins from Human Blood Platelets, Are C-terminal Deletion Products of CXC Chemokines* , 2000, The Journal of Biological Chemistry.

[17]  H. Nikaido,et al.  The role of outer membrane and efflux pumps in the resistance of gram-negative bacteria. Can we improve drug access? , 1998, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

[18]  D. Legrand,et al.  Lactoferrin , 2005, Cellular and Molecular Life Sciences.

[19]  Ø. Rekdal,et al.  Lactoferricin of bovine origin is more active than lactoferricins of human, murine and caprine origin. , 1998, Scandinavian journal of infectious diseases.

[20]  J. Mcghee,et al.  A bactericidal effect for human lactoferrin. , 1977, Science.

[21]  Carla P. Guimarães,et al.  Sortase A as a tool for high‐yield histatin cyclization , 2011, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[22]  K Sandvik,et al.  The antimicrobial peptides lactoferricin B and magainin 2 cross over the bacterial cytoplasmic membrane and reside in the cytoplasm , 2001, FEBS letters.

[23]  Y. Shai,et al.  Cyclization of a cytolytic amphipathic alpha-helical peptide and its diastereomer: effect on structure, interaction with model membranes, and biological function. , 2000, Biochemistry.

[24]  H. Baker,et al.  A structural framework for understanding the multifunctional character of lactoferrin. , 2009, Biochimie.

[25]  Christopher J. White,et al.  Contemporary strategies for peptide macrocyclization. , 2011, Nature chemistry.

[26]  R. Hancock,et al.  Antimicrobial properties of lactoferrin. , 2009, Biochimie.

[27]  K. Brehm,et al.  Characterization of S3Pvac Anti-Cysticercosis Vaccine Components: Implications for the Development of an Anti-Cestodiasis Vaccine , 2010, PLoS ONE.

[28]  Miguel Calvo Rebollar,et al.  Biological role of lactoferrin. , 1992, Archives of disease in childhood.

[29]  K. Yamauchi,et al.  Identification of the bactericidal domain of lactoferrin. , 1992, Biochimica et biophysica acta.

[30]  H. Vogel,et al.  Structural and biophysical characterization of an antimicrobial peptide chimera comprised of lactoferricin and lactoferrampin. , 2012, Biochimica et biophysica acta.

[31]  A. Naito,et al.  Interactions of bovine lactoferricin with acidic phospholipid bilayers and its antimicrobial activity as studied by solid-state NMR. , 2006, Biochimica et biophysica acta.

[32]  M. Dathe,et al.  Cyclization increases the antimicrobial activity and selectivity of arginine- and tryptophan-containing hexapeptides. , 2004, Biochemistry.

[33]  E. Veerman,et al.  Bactericidal activity of LFchimera is stronger and less sensitive to ionic strength than its constituent lactoferricin and lactoferrampin peptides. , 2009, Biochimie.

[34]  R. Hancock,et al.  Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances , 2008, Nature Protocols.

[35]  Ø. Samuelsen,et al.  Lactoferricin B inhibits bacterial macromolecular synthesis in Escherichia coli and Bacillus subtilis. , 2004, FEMS microbiology letters.

[36]  H. Vogel.  Lactoferrin, a bird's eye view. , 2012, Biochemistry and cell biology = Biochimie et biologie cellulaire.

[37]  LatorreDaniela,et al.  LF immunomodulatory strategies: mastering bacterial endotoxin11This article is part of a Special Issue entitled Lactoferrin and has undergone the Journal's usual peer review process. , 2012 .

[38]  H. Vogel,et al.  Three-dimensional solution structure of lactoferricin B, an antimicrobial peptide derived from bovine lactoferrin. , 1998, Biochemistry.

[39]  D. Crommelin.  Influence of lipid composition and ionic strength on the physical stability of liposomes. , 1984, Journal of pharmaceutical sciences.

[40]  R. Arnold,et al.  Bactericidal Activity of Human Lactoferrin: Differentiation from the Stasis of Iron Deprivation , 1982, Infection and immunity.

[41]  M. Meldal,et al.  Maintaining biological activity by using triazoles as disulfide bond mimetics. , 2011, Angewandte Chemie.

[42]  M. Finn,et al.  "Clickable" agarose for affinity chromatography. , 2005, Bioconjugate chemistry.

[43]  I. Chaiken,et al.  Click Chemistry in Peptide-Based Drug Design , 2013, Molecules.

[44]  J. Svendsen,et al.  Important structural features of 15-residue lactoferricin derivatives and methods for improvement of antimicrobial activity. , 2002, Biochemistry and cell biology = Biochimie et biologie cellulaire.

[45]  Marco M. Domingues,et al.  What can light scattering spectroscopy do for membrane‐active peptide studies? , 2008, Journal of peptide science : an official publication of the European Peptide Society.

[46]  Hans J. Vogel,et al.  Serum Stabilities of Short Tryptophan- and Arginine-Rich Antimicrobial Peptide Analogs , 2010, PloS one.

[47]  R. Epand,et al.  Depolarization, Bacterial Membrane Composition, and the Antimicrobial Action of Ceragenins , 2010, Antimicrobial Agents and Chemotherapy.

[48]  H. Vogel,et al.  Human Lactoferricin Is Partially Folded in Aqueous Solution and Is Better Stabilized in a Membrane Mimetic Solvent , 2005, Antimicrobial Agents and Chemotherapy.